Table 1 Clinical characteristics of the participants with COVID-19.

Characteristic

Age, years

27[19.5–48]

23[20–33]

0.267^b

Sex, n(%)

Male

9(42.9)

12(37.5)

0.697^b

Female

12(47.1)

20(62.5)

Epidemiology, n(%)

Returning from

 United Kingdom

11(52.4)

15(46.9)

0.695^b

 Others

10(47.6)

17(53.1)

Exposure to confirmed or suspected patients

14(66.7)

18(56.2)

0.448^b

Comorbidities, n(%)

 With chronic disease*

3(14.3)

4(2.5)

1.000^b

 Without chronic disease

18(85.7)

28(87.5)

Current smoker, n(%)

6(28.6)

7(21.9)

0.579^b

Vital signs on admission

Temperature, °C

36.9[36.6–37.4]

37.05[36.8–37.3]

0.356^a

Respiratory rate, TPM

18.0[18.0–19.0]

18.0[17.0–20.0]

0.042^a

SpO₂, %

97.0[96.0–98.0]

97.0[96.0–98.0]

0.767^a

Systolic blood pressure, mmHg

123[105–128]

124[119–131]

0.107^a

Heart rate, BPM

73.0[63.5–96.5]

69[65.25–77]

0.566^a

Onset of symptoms to hospital admission, days

3.0[2.0–11.0]

4.5[2.0–8.0]

0.790^a

Severity status score

qSOFA ≥ 1

0[0–1]

0[0–1]

0.127^a

SIRS

1[1–2]

1[0–2]

0.109^a

APACHE II

2[0–2]

2[0–2]

0.977^a

CURB-65 ≥ 1

0[0–0]

0[0–0]

0.345^a

MEWS ≥ 3

2[1–3]

1.5[0–3]

0.093^a

Signs and symptoms on admission, n(%)

Fever

5(23.8)

15(46.8)

0.090^b

Chills

2(9.52)

4(12.5)

1.000^b

Cough

11(52.4)

17(53.1)

0.958^b

Sputum

5(23.8)

6(18.8)

0.922^b

Chest pain

2(9.52)

4(12.5)

1.000^b

Dyspnoea

7(33.3)

6(18.8)

0.227^b

Rhinobyon/rhinorrhoea

6(28.6)

12(37.5)

0.433^b

Sore throat or dryness

12(57.1)

15(46.8)

0.465^b

Headache/dizziness

8(38.1)

11(34.4)

0.782^b

Malaise/fatigue

5(23.8)

3(9.38)

0.297^b

Myalgia or arthralgia

4(19.0)

6(18.8)

1.000^b

Nausea/vomiting/anorexia/diarrhoea

8(38.1)

8(25.0)

0.310^b